In the run-up to the 2020 election, all 20 Democratic presidential candidates promised voters they’d pursue bold changes to health care, such as a government-run insurance plan or expanding Medicare to cover every American. Fast-forward to the congressional stalemate that has closed the federal government for more than a month. Democrats, entrenched on one side…
A cancer patient might live in a town with four oncology groups, but only one accepts his insurance — the one owned by his insurer. A young couple could see huge bills after their child is born, because their insurer agreed to the health system’s rates in exchange for a contract with obstetricians across the…
Kai Romero is Head of Clinical Success at Evidently. The company is one of many that are using AI to dive into the EMR and extract data to deliver it to clinicians. It works to get really great information from the EMR to various flavors of clinicians in a fast and innovative way. Kai leads…
Philips is using its patient monitoring devices to help health systems deliver care more efficiently, especially in areas with specialist shortages. The company’s connected devices enable continuous monitoring from home to hospital and back, which can reduce diagnostic delays and improve patient safety, said Nick Wilson, Philps’ vice president of product. The post How Philips…
Amae Health’s Series B round was led by Altos Ventures and included participation from Quiet Capital, Bling Capital, Cedars-Sinai Ventures, Healthier Capital and 8VC. The post Amae Health Raises $25M to Improve Care for Severe Mental Illness appeared first on MedCity News.
Pfizer’s offer of up to $86.25 in cash for each share of obesity drugs developer Metsera share tops the up to $86.20 Novo Nordisk was willing to pay. The financial consideration and the greater certainly of a deal close tipped the balance in Pfizer’s favor, ending a bidding war for Metsera and its next-generation obesity…
This one-page fact sheet provides basic information for understanding measures of hospital finances. It describes profits margins and other common measures of hospitals’ financial well-being, as well as considerations when evaluating reports of these measures, such as how different approaches can make these measures appear higher or lower.
To shift wearables from wellness tools to useful drivers of disease management, the data they generate must be as trustworthy as it is plentiful. Clear frameworks that govern how information is gathered and used are needed, along with standards for the accuracy and reliability of devices The post Stronger Data Governance and Reliability Standards Needed…
We urgently need biomarkers that are sensitive, objective, and practical. Eye-movement measures are ready to fill this gap, not as distant innovations, but as tools available today. The post More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases appeared first on MedCity News.
While for years patient engagement has been seen as a valuable, starting in 2026 this will be a legal mandate. Plans offering essential health benefits must appoint at least 1 patient representative to their pharmacy and therapeutics (P&T) committees by the start of 2026.1 After July 10, 2026, every state Medicaid program must establish standalone Beneficiary…